Patents by Inventor Peggy Huang

Peggy Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF
    Publication number: 20140243340
    Abstract: The present invention features compounds of formula I or pharmaceutically acceptable salts, solvates or prodrugs thereof, and methods of using the same to inhibit the metabolizing activities of CYP enzymes. The present invention also features methods of using these compounds, salts, solvates or prodrugs to improve the pharmacokinetics of drugs that are metabolized by CYP enzymes.
    Type: Application
    Filed: May 8, 2014
    Publication date: August 28, 2014
    Applicant: AbbVie Inc.
    Inventors: Larry L. Klein, Hui-Ju CHEN, Ming C. YEUNG, Charles A. Flentge, John T. Randolph, Peggy Huang, Douglas K. Hutchinson, Dale J. Kempf
  • Compounds that are useful for improving pharmacokinetics
    Patent number: 8741938
    Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: June 3, 2014
    Assignee: AbbVie Inc.
    Inventors: Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy Huang, Larry L. Klein
  • NOVEL COMPOUNDS THAT ARE USEFUL FOR IMPROVING PHARMACOKINETICS
    Publication number: 20130317071
    Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
    Type: Application
    Filed: July 30, 2013
    Publication date: November 28, 2013
    Inventors: Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy Huang, Larry L. Klein
  • Compounds that are useful for improving pharmacokinetics
    Patent number: 8524753
    Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: September 3, 2013
    Assignee: AbbVie Inc.
    Inventors: Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy Huang, Larry L. Klein
  • NOVEL COMPOUNDS THAT ARE USEFUL FOR IMPROVING PHARMACOKINETICS
    Publication number: 20120184559
    Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
    Type: Application
    Filed: January 31, 2012
    Publication date: July 19, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy Huang, Larry L. Klein
  • Compounds that are useful for improving pharmacokinetics
    Patent number: 7786153
    Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: August 31, 2010
    Assignee: Abbott Laboratories Inc.
    Inventors: Dale J. Kempf, Charles A. Flentge, John T. Randolph, Peggy Huang, Larry L. Klein
  • Anti-infective agents
    Publication number: 20060287300
    Abstract: Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
    Type: Application
    Filed: February 27, 2006
    Publication date: December 21, 2006
    Inventors: Larry Klein, Peggy Huang, John Randolph, Douglas Hutchinson, Ming Yeung, Charles Flentge
  • Novel compounds that are useful for improving pharmacokinetics
    Publication number: 20060199851
    Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
    Type: Application
    Filed: March 2, 2006
    Publication date: September 7, 2006
    Inventors: Dale Kempf, Charles Flentge, John Randolph, Peggy Huang, Larry Klein
  • HIV protease inhibiting compounds
    Publication number: 20050159469
    Abstract: A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
    Type: Application
    Filed: December 10, 2004
    Publication date: July 21, 2005
    Inventors: John Randolph, Hui-Ju Chen, David DeGoey, Charles Flentge, William Flosi, David Grampovnik, Peggy Huang, Douglas Hutchinson, Dale Kempf, Larry Klein, Ming Yeung
  • HIV protease inhibiting compounds
    Publication number: 20050131042
    Abstract: A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
    Type: Application
    Filed: December 11, 2003
    Publication date: June 16, 2005
    Inventors: Charles Flentge, Hui-Ju Chen, David DeGoey, William Flosi, David Grampovnik, Peggy Huang, Dale Kempf, Larry Klein, Allan Krueger, Darold Madigan, John Randolph, Minghua Sun, Ming Yeung, Chen Zhao
  • Anti-infective agents
    Publication number: 20050107364
    Abstract: Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
    Type: Application
    Filed: August 24, 2004
    Publication date: May 19, 2005
    Inventors: Douglas Hutchinson, John Bellettini, David Betebenner, Richard Bishop, Thomas Borchardt, Todd Bosse, Russell Cink, Charles Flentge, Bradley Gates, Brian Green, Mira Hinman, Peggy Huang, Larry Klein, Allan Krueger, Daniel Larson, M. Leanna, Dachun Liu, Darold Madigan, Keith McDaniel, John Randolph, Todd Rockway, Teresa Rosenberg, Kent Stewart, Vincent Stoll, Rolf Wagner, Ming Yeung